Clinical features and risk factors of bilateral granulomatous lobular mastitis

Tingting Ge,Ping Sun,Xue Feng,Xiang Gao,Shuang Gao,Tangshun Wang,Xiaoguang Shi
DOI: https://doi.org/10.1097/md.0000000000037854
IF: 1.6
2024-04-27
Medicine
Abstract:Granulomatous Lobular Mastitis (GLM), also known as idiopathic granulomatous mastitis s, is a type of non-puerperal mastitis. It is characterized by a palpable breast mass, which can rapidly progress to abscess formation and rupture. In some cases, patients may also experience accompanying symptoms such as low-grade fever, dry cough, lower limb erythema, and arthritis. [ 1 ] GLM was previously considered a rare chronic benign inflammatory breast disease, but its incidence has been rapidly increasing in the past 20 years. As of 2021, the Chinese Society of Breast Surgery has published Clinical Practice Guidelines for patients with non-lactational mastitis. [ 2 ] Various therapies such as steroids, [ 3 ] immunosuppressants, [ 4 ] antibiotics, [ 5 ] and surgical excision [ 6 ] are the main approaches. The choice of treatment method primarily depends on the clinical physician diagnostic habits and experience. In our hospital, a systematic and standardized treatment process has been developed in the long-term clinical treatment. In the retrospective analysis of 1309 patients who received standardized treatment, the recurrence rate was found to be approximately 3.8%. However, with an increase in the number of cases accumulated, a gradual increase in the number of patients with bilateral morbidity was observed.
medicine, general & internal
What problem does this paper attempt to address?